Zolpidem modulates GABAA receptor function in subthalamic nucleus

Neuroscience Research

Volumn 58, Issue 1, 2007, Pages 77-85

  Chen, Lei ^a,b   Xie, Jun Xia ^b   Fung, Kam Shuen ^a   Yung, Wing Ho ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b QINGDAO UNIVERSITY   (China)

Author keywords

GABAA receptor; Subthalamic nucleus; Zolpidem

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; FLUMAZENIL; ZOLPIDEM;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; INHIBITORY POSTSYNAPTIC POTENTIAL; MICROINJECTION; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; ROTATION; SUBTHALAMIC NUCLEUS; WHOLE CELL;

ANIMALS; FLUMAZENIL; GABA AGONISTS; GABA MODULATORS; GAMMA-AMINOBUTYRIC ACID; MOTOR ACTIVITY; NEURAL INHIBITION; NEURAL PATHWAYS; NEURONS; ORGAN CULTURE TECHNIQUES; PARKINSON DISEASE; PATCH-CLAMP TECHNIQUES; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; RECEPTORS, GABA-A; SUBTHALAMIC NUCLEUS; SYNAPTIC TRANSMISSION; TIME FACTORS;

EID: 34247595463     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2007.02.002     Document Type: Article

References (51)

1. Albin R.L., Young A.B., and Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci. 12 (1989) 366-375
2. Baufreton J., Garret M., Dovero S., Dufy B., Bioulac B., and Taupignon A. Activation of GABA(A) receptors in subthalamic neurons in vitro: properties of native receptors and inhibition mechanisms. J. Neurophysiol. 86 (2001) 75-85
3. Bergman H., Wichmann T., and DeLong M.R. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 249 (1990) 1436-1438
4. Bevan M.D., Magill P.J., Hallworth N.E., Bolam J.P., and Wilson C.J. Regulation of the timing and pattern of action potential generation in rat subthalamic neurons in vitro by GABA-A IPSPs. J. Neurophysiol. 87 (2002) 1348-1362
5. Bevan M.D., Magill P.J., Terman D., Bolam J.P., and Wilson C.J. Move to the rhythm: oscillations in the subthalamic nucleus-external globus pallidus network. Trends Neurosci. 25 (2002) 525-531
6. Bolam J.P., Hanley J.J., Booth P.A., and Bevan M.D. Synaptic organisation of the basal ganglia. J. Anat. 196 (2000) 527-542
7. Chabardes S., Kahane P., Minotti L., Koudsie A., Hirsch E., and Benabid A.L. Deep brain stimulation in epilepsy with particular reference to the subthalamic nucleus. Epileptic. Disord. 3 (2002) S83-S93
8. Chen L., and Yung W.H. Tonic activation of presynaptic GABA(B) receptors on rat pallidosubthalamic terminals. Acta Pharmacol. Sin. 26 (2005) 10-16
9. Chen L., Chan C.S., and Yung W.H. Electrophysiological and behavioral effects of zolpidem in rat globus pallidus. Exp. Neurol. 186 (2004) 212-220
10. Cohen A.S., Lin D.D., and Coulter D.A. Protracted postnatal development of inhibitory synaptic transmission in rat hippocampal area CA1 neurons. J. Neurophysiol. 84 (2000) 2465-2476
11. Costa E. From GABAA receptor diversity emerges a unified vision of GABAergic inhibition. Annu. Rev. Pharmacol. Toxicol. 38 (1998) 321-350
12. Criswell H.E., McCown T.J., Moy S.S., Oxford G.S., Mueller R.A., Morrow A.L., and Breese G.R. Action of zolpidem on responses to GABA in relation to mRNAs for GABA(A) receptor alpha subunits within single cells: evidence for multiple functional GABA(A) isoreceptors on individual neurons. Neuropharmacology 36 (1997) 1641-1652
13. Daniele A., Albanese A., Gainotti G., Gregori B., and Bartolomeo P. Zolpidem in Parkinson's disease. Lancet 349 (1997) 1222-1223
14. Defazio T., and Hablitz J.J. Zinc and zolpidem modulate mIPSCs in rat neocortical pyramidal neurons. J. Neurophysiol. 80 (1998) 1670-1677
15. Defazio R.A., and Hablitz J.J. Reduction of zolpidem sensitivity in a freeze lesion model of neocortical dysgenesis. J. Neurophysiol. 81 (1999) 404-407
16. DeLong M.R. Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 13 (1990) 281-285
17. Dennis T., Dubois A., Benavides J., and Scatton B. Distribution of central omega 1 (benzodiazepine1) and omega 2 (benzodiazepine2) receptor subtypes in the monkey and human brain. An autoradiographic study with [3H]flunitrazepam and the omega 1 selective ligand [3H]zolpidem. J. Pharmacol. Exp. Ther. 247 (1988) 309-322
18. De Sarro G., Chimirri A., McKernan R., Quirk K., Giusti P., and De Sarro A. Anticonvulsant activity of azirino[1,2-d][1,4]benzodiazepines and related 1,4-benzodiazepines in mice. Pharmacol. Biochem. Behav. 58 (1997) 281-289
19. Duncan G.E., Breese G.R., Criswell H.E., McCown T.J., Herbert J.S., Devaud L.L., and Morrow A.L. Distribution of [3H]zolpidem binding sites in relation to messenger RNA encoding the alpha 1, beta 2 and gamma 2 subunits of GABAA receptors in rat brain. Neuroscience 64 (1995) 1113-1128
20. Farver D.K., and Khan M.H. Zolpidem for antipsychotic-induced parkinsonism. Ann. Pharmacother. 35 (2001) 435-437
21. Hájos N., Nusser Z., Rancz E.A., Freund T.F., and Mody I. Cell type- and synapse-specific variability in synaptic GABAA receptor occupancy. Eur. J. Neurosci. 12 (2000) 810-818
22. Hollrigel G.S., and Soltesz I. Slow kinetics of miniature IPSCs during early postnatal development in granule cells of the dentate gyrus. J. Neurosci. 17 (1997) 5119-5128
23. Jankovic J., and Marsden C.D. Therapeutic strategies in Parkinson's disease. In: Jankovic J., and Tolosa E. (Eds). Parkinson's Diseases and Movement Disorders (1988), Baltimore and Munich, Urban and Schwarzenberg 95-119
24. Kapur J., and Macdonald R.L. Rapid seizure-induced reduction of benzodiazepine and zinc sensitivity of hippocampal dentate granule cell GABAA receptors. J. Neurosci. 17 (1997) 7532-7540
25. Krack P., Benazzouz A., Pollak P., Limousin P., Piallat B., Hoffmann D., Xie J., and Benabid A.L. Treatment of tremor in Parkinson's disease by subthalamic nucleus stimulation. Mov. Disord. 13 (1998) 907-914
26. Limousin P., Pollak P., Benazzouz A., Hoffmann D., Le Bas J.F., Broussolle E., Perret J.E., and Benabid A.L. Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 345 (1995) 91-95
27. Magill P.J., Bolam J.P., and Bevan M.D. Relationship of activity in the subthalamic nucleus-globus pallidus network to cortical electroencephalogram. J. Neurosci. 20 (2000) 820-833
28. Magill P.J., Bolam J.P., and Bevan M.D. Dopamine regulates the impact of the cerebral cortex on the subthalamic nucleus-globus pallidus network. Neuroscience 106 (2001) 313-330
29. Mehta A.K., and Ticku M.K. An update on GABAA receptors. Brain Res. Brain Res. Rev. 29 (1999) 196-217
30. Murer M.G., and Pazo J.H. Circling behaviour induced by activation of GABAA receptors in the subthalamic nucleus. Neuroreport 4 (1993) 1219-1222
31. Niddam R., Dubois A., Scatton B., Arbilla S., and Langer S.Z. Autoradiographic localization of [3H]zolpidem binding sites in the rat CNS: comparison with the distribution of [3H]flunitrazepam binding sites. J. Neurochem. 49 (1987) 890-899
32. Obeso J.A., Rodriguez M.C., Gorospe A., Guridi J., Alvarez L., and Macias R. Surgical treatment of Parkinson's disease. Baillieres Clin. Neurol. 6 (1997) 125-145
33. Olsen R.W., Bureau M., Houser C.R., Delgado-Escueta A.V., Richards J.G., and Möhler H. GABA/benzodiazepine receptors in human focal epilepsy. Epilepsy Res. 8 (1992) 383-391
34. Perrais D., and Ropert N. Effect of zolpidem on miniature IPSCs and occupancy of postsynaptic GABAA receptors in central synapses. J. Neurosci. 19 (1999) 578-588
35. Plenz D., and Kital S.T. A basal ganglia pacemaker formed by the subthalamic nucleus and external globus pallidus. Nature 400 (1999) 677-682
36. Pycock C. Turning behavior in animal. Neuroscience 5 (1980) 461-514
37. Rogers C.J., Twyman R.E., and Macdonald R.L. Benzodiazepine and beta-carboline regulation of single GABAA receptor channels of mouse spinal neurones in culture. J. Physiol. 475 (1994) 69-82
38. Rudolph U., Crestani F., and Mohler H. GABA(A) receptor subtypes: dissecting their pharmacological functions. Trends Pharmacol. Sci. 22 (2001) 188-194
39. Ruzicka E., Roth J., Jech R., and Busek P. Subhypnotic doses of zolpidem oppose dopaminergic-induced dyskinesia in Parkinson's disease. Mov. Disord. 15 (2000) 734-735
40. Sanger D.J., Morel E., and Perrault G. Comparison of the pharmacological profiles of the hypnotic drugs, zaleplon and zolpidem. Eur. J. Pharmacol. 313 (1996) 35-42
41. Sieghart W. Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes. Pharmacol. Rev. 47 (1995) 181-234
42. Smith Y., Bevan M.D., Shink E., and Bolam J.P. Microcircuitry of the direct and indirect pathways of the basal ganglia. Neuroscience 86 (1998) 353-387
43. Smith Y., Bolam J.P., and Von Krosigk M. Topographical and synaptic organization of the GABA-containing pallidosubthalamic projection in the rat. Eur. J. Neurosci. 2 (1990) 500-511
44. Smith Y., and Parent A. Neurons of the subthalamic nucleus in primates display glutamate but not GABA immunoreactivity. Brain Res. 453 (1988) 353-356
45. Study R.E., and Barker J.L. Diazepam and pentobarbital: fluctuation analysis reveals different mechanisms for potentiation of gamma-aminobutyric acid responses in cultured central neurons. Proc. Natl. Acad. Sci. U.S.A. 78 (1981) 7180-7184
46. Taketo M., and Yoshioka T. Developmental change of GABA(A) receptor-mediated current in rat hippocampus. Neuroscience 96 (2000) 507-514
47. Usui N., Maesawa S., Kajita Y., Endo O., Takebayashi S., and Yoshida J. Suppression of secondary generalization of limbic seizures by stimulation of subthalamic nucleus in rats. J. Neurosurg. 102 (2005) 1122-1129
48. Veliskova J., Velsek L., and Moshe S.L. Subthalamic nucleus: a new anticonvulsant site in the brain. Neuroreport 7 (1996) 1786-1788
49. Vicini S., Ferguson C., Prybylowski K., Kralic J., Morrow A.L., and Homanics G.E. GABA(A) receptor alpha1 subunit deletion prevents developmental changes of inhibitory synaptic currents in cerebellar neurons. J. Neurosci. 21 (2001) 3009-3016
50. Wilson C.L., Puntis M., and Lacey M.G. Overwhelmingly asynchronous firing of rat subthalamic nucleus neurones in brain slices provides little evidence for intrinsic interconnectivity. Neuroscience 123 (2004) 187-200
51. Wisden W., Laurie D.J., Monyer H., and Seeburg P.H. The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J. Neurosci. 12 (1992) 1040-1062